Member Info for VertizeaSun

Hey Thorn.....Are you driving to Verona? I guess if you are in town for your daughters graduation you've given the aircrew the week off.

Next week's deal will be your 20p share placing.

This report is a very expensive way of repeating everything Simon Bennett is already telling potential partners/buyers etc. So who is it actually written for? I gave up on it.

Secondly:

"Are Affimer proteins patented or open for public use"

Affimer proteins are patented and not open for unrestricted public use. The core Affimer technology is protected by a robust portfolio of patents held by Avacta Group plc, covering key territories including the United States, Europe, China, Japan, and others. The foundational patent (such as PCT/GB2014/050435) is owned by the University of Leeds and licensed exclusively to Avacta Ltd.

While Affimer reagents can be accessed commercially through Avacta Life Sciences or via academic collaborations with the University of Leeds, their use is subject to licensing agreements and is not considered open-source or free for public use without appropriate authorization.

I asked Perplexity:

"Is Affimer molecular technology generic or proprietary to Avacta PLC"

Affimer molecular technology is proprietary to Avacta PLC. The company describes Affimer® technology as its own novel class of biologicals, based on the human protein Stefin A, and refers to it consistently as "proprietary" in its official materials. Avacta develops, owns, and licenses this platform, and has entered into exclusive licensing agreements with partners such as Moderna and LG Chem, who access the technology under specific terms, rather than as a generic or open platform. The technology is positioned as a proprietary alternative to antibodies, with unique advantages and applications in therapeutics, diagnostics, and research.

Don't forget the old one:

Never wrestle a pig - you'll get plastered in mud and the pig enjoys it.

Derek.....unnecessary dilution does matter.

"the chance to buy at a cracking discount to current SP"

Despite it short-changing your own company. Odd.

What did you specialise in fantasy boy ?'.

Too polite in my opinion. I'm still waiting on an answer to his pre|CISION® V3 fantasy.

SandyR....thanks for that new information. I didn't know or my likely my addled brain had totally forgotten.

Yes and no Thompi.....am I correct in thinking Avacta declined to join the last fund raising round and consequentially saw its shareholding reduced to 21% from 25%?

Of course Eggy knew.

Forward it to Simon Bennett.

Touché DG

Eggy trying to be clever...again. And failing...again.

Response: an answer or reaction:

Responder: can refer to various concepts, including a certified first responder who provides emergency care, a community first responder, or a British police drama series titled "The Responder."

This might do:

https://x.com/EggySoldier

Wrong one?

Ice......or Thorn's old favourite - not buying back in until Avacta produced pre|CISION® V3.

I wonder how much difference the Fast Tracking etc will make in the real world? Pharma companies will still be dealing with exactly the same levels of bureaucracy and regulation as currently imposed.....no matter how irrelevant. Font sizes on packaging anyone? As it takes roughly ten years to go from drawing board into a paying patient's arm and AVA6000 is probably in year 8 I'm not sure where the corner cutting will be coming from?

Perhaps BV knows of concrete improvements other than the regulators responding in 45 days instead of 60?

Ice......that's the point I'm making.....the AGM should be explosive because Avacta must by now have a Plan A. It would be criminal not to.

AGM update could be explosive.......It has to be because we need a partner to actually fund the manufacturing of the compound. Avacta doesn't have enough cash.

speaking of anglo-saxon expletive and thanks to x:

capt. chaos

@andrewdigby3

·

46m

**** me, i dreaming of the day we may actually make a move north, taking into consideration what we have it’s soul destroying seeing the sp at 30p #avct